Nabiximols in Multiple Sclerosis: Beyond Spasticity-An Exploratory Systematic Review and Meta-Analysis of Symptomatic Outcomes. (PubMed, Med Sci (Basel)) - Jul 28, 2026 - " Beyond spasticity, nabiximols may represent a signal of benefit for bladder function, sleep disruption, spasm quality, and gait function in MS, in line with the "spasticity-plus" concept. However, the evidence certainty was low to very low, and these findings should be considered exploratory." Clinical • Journal • Retrospective data • Review • CNS Disorders • Movement Disorders • Multiple Sclerosis • Sleep Disorder
|
|
Dénes Kleiner; Dóra Mátis; Gábor Fazekas; István László Horváth; Katalin Lugosi; Péter Fehérvári; Péter Hegyi; Rita Nagy
|